However, there remains limited understanding of the functional impact of SIRPG risk variants on SIRP:CD47 signaling and downstream immune cell activation and proliferation, as well as on pancreatic β-cell survival and function in the context of T1D pathogenesis. This evidence concerns the gene SIRPG and type 1 diabetes mellitus.